Serum ANGPTL6 levels could distinguish early HCC patients with normal serum AFP levels from CHB patients (AUC = 0.684) with 96.67% specificity and could distinguish early HCC patients with normal serum AFP levels from HCs (AUC = 0.747) with 84.37% sensitivity. Here, ANGPTL6 is linked to hepatocellular carcinoma.